Somnus Therapeutics, Inc.
Insomnia Therapeutics
Somnus Therapeautics Insomnia
Somnus Therapeautics Insomnia Somnus Therapeutics Somnus Therapeautics Insomnia Somnus Therapeutics Insomnia Product Somnus Therapeautics Insomnia Insomnia Information from Somnus Therapeutics Somnus Therapeautics Insomnia Somnus Therapeutics News and Events Somnus Therapeautics Insomnia Contact the Insomnia Specialists Somnus Therapeutics Somnus Therapeautics Insomnia
Somnus Therapeautics Insomnia
  overview
Somnus Therapeutics Insomnia
  about
Somnus Therapeutics Insomnia
  sleep & insomnia
Somnus Therapeutics Insomnia
  press releases
Somnus Therapeutics Insomnia
  information
Somnus Therapeutics Insomnia
  management
 
  publications
  directions
  board of directors
  research presentations
  scientific advisors
         

Jack W. Britts, President and CEO, Merz Pharmaceuticals USA

  • Group Vice President, Marketing and Commercial Planning; Sepracor, Inc. (respiratory and CNS drug discovery and development, including Xopenex®, LUNESTA®)
  • Vice President, GI Therapeutic Area Leader, AstraZeneca Pharmaceuticals (Prilosec®, Nexium®) and various marketing management positions in product portfolio, international, cardiovascular and respiratory areas.



 
Somnus Therapeautics Insomnia
Somnus Therapeautics Insomnia